BioPharma Dive ٢٠ يناير ٢٠٢٦ Kailera’s Ron Renaud on how a China-linked startup can compete in obesity
BioPharma Dive ٢٠ يناير ٢٠٢٦ When every day counts: Building CRO partnerships on a foundation of trust, care and precision
BioPharma Dive ١٦ يناير ٢٠٢٦ Wegovy pill off to a fast start; Ex-Emergent CEO sued for insider trading
BioPharma Dive ١٤ يناير ٢٠٢٦ JPM26: Paying cash for obesity drugs, renewed IPO optimism and pharma’s cell therapy view
BioPharma Dive ١٤ يناير ٢٠٢٦ Lilly, chasing Novo, expects second-quarter FDA decision on obesity pill